Promoting dental implant stability in edentulous adults Oral Health
Conditions
Interventions
This is a randomized, controlled clinical trial including 32 dental implants placed in medically healthy adult patients (18–60 years old), divided equally into four groups (n = 8 implants/group).
Gro
Sponsors
University of Sulaimani
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Patients aged 18–60 years with missing teeth. 2. Systemically healthy individuals. 3. Patients with bone density D3 at the site of implant placement. 4. Presence of adequate bone height minimum of 10 mm above the anatomical landmarks and adequate width, so that 1.5–2 mm of bone is present all around the implants after implant placement. 5. Bone crest healing period of more than 3 months before implant placement. 6. Good oral hygiene and compliance with follow-up appointments. 7. No known allergies to simvastatin or hyaluronic acid.
Exclusion criteria
Exclusion criteria: 1. Patients with uncontrolled systemic diseases. 2. Patients who are chronic smokers. 3. Pregnant and lactating women. 4. Patients with a history of chemotherapy or radiotherapy in the last 6 months. 5. Patients with blood dyscrasias. 6. Patients with parafunctional habits like bruxism. 7. Patients with poor oral hygiene and untreated periodontal disease. 8. Patients with a history of allergy to SMV or HA. 9. Alcoholic patients or alcohol users. 10. Patients with active liver disease and those on Warfarin and/or antifungal medication.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Implant Stability Quotient (ISQ) values measured at three time points (immediate, 40 days, and 60 days post-implantation) using resonance frequency analysis. | — |
Secondary
| Measure | Time frame |
|---|---|
| There are no secondary outcome measures | — |
Countries
Iraq
Contacts
Public ContactAhmed Mohammed
Outcome results
None listed